**INTRODUCTION:** Generic preference-based health-related quality-of-life measures such as the EuroQol-5D (EQ-5D) are increasingly used as an outcome measure. They are most useful in economic evaluations, as they can be used to obtain the quality adjusted life years (QALY) of interventions. Evaluations that use QALY are currently the preferred method for evaluating cost-effectiveness as they allow for comparison across interventions and conditions and are capable of incorporating a societal perspective. The EQ-5D is the gold standard for obtaining such QALYs, yet no EQ-5D reference values are available for the different breast reconstruction (BR) techniques, preventing state-of-the-art cost-effectiveness evaluations of BR. Therefore, we aimed to evaluate the EQ-5D-5L in patients who had undergone postmastectomy BR for breast cancer.

**METHODS:** This multi-center cross-sectional survey study included women who had been randomly selected from a 10-year cohort and who had previously undergone a mastectomy for breast cancer either followed by an autologous-BR, an implant-BR or who had not undergone BR. These women were asked to complete the reconstruction module of the Breast-Q, the EORTC-C30 and EORTC-BR23 quality of life questionnaires and the EQ-5D. Propensity score matching was used to compensate for selection bias originating from pretreatment differences between the patient groups.

**RESULTS:** After matching of the patient groups the EQ-5D QoL-index-score of either autologous-BR and implant-BR did not differ significantly from one another. However, both showed significantly better QoL-index-scores than patients who had not received a postmastectomy BR. Autologous-BR patients who had experienced complications during treatment reported significantly more pain/discomfort than implant-BR who had experienced complications; an effect that remained over time. Over three-quarters of autologous-BR patients compared to half of implant-BR patients reported pain symptoms; an effect that was not detected by the Breast-Q questionnaire.

**CONCLUSION:** In a propensity score-matched comparison of societal preference-based QoL using the EQ-5D we found that overall autologous-BR and implant-BR did not differ significantly from one another but both showed better QoL in comparison to mastectomy only patients. Furthermore, autologous BR-patients who experienced complications during treatment persistently reported more pain/discomfort than implant-BR patients that had complications. The BR QoL reference values from this study will allow state-of-the-art cost-effectiveness studies using QALYs to be conducted.
